Showing results (11-20 of 313) with videos related to
Sort By:
Pageof 32
Clinical Genetics|July 16, 2003
Nine novel mutations in the protoporphyrinogen oxidase gene in Swedish families with variegate porphyriaA Wiman, P Harper, Y FloderusScandinavian Journal of Clinical and Laboratory Investigation|February 24, 2001
Porphyrins, porphyrin metabolism and porphyrias. IV. Pathophysiology of erythyropoietic protoporphyria--diagnosis, care and monitoring of the patientS Thunell, P Harper, A BrunJournal of Internal Medicine|November 14, 1997
Large phlebotomy in variegate porphyriaP Harper, T Hybinette, S ThunellJournal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie|November 1, 1989
Mutations in acute intermittent porphyria detected by ELISA measurement of porphobilinogen deaminaseL Lannfelt, L Wetterberg, P Gellerfors, et al.Journal of Internal Medicine|April 24, 2010
Erythropoietic protoporphyria in Sweden: demographic, clinical, biochemical and genetic characteristicsS Wahlin, Y Floderus, P Stål, et al.Clinical Genetics|October 10, 2002
Acute intermittent porphyria in Sweden. Molecular, functional and clinical consequences of some new mutations found in the porphobilinogen deaminase geneY Floderus, P M Shoolingin-Jordan, P HarperArchives of Environmental Health|August 5, 1999
Porphyrin status in aluminum foundry workers exposed to hexachlorobenzene and octachlorostyreneA I Seldén, Y Floderus, L S Bodin, et al.Clinical Genetics|January 15, 2011
Identification of an AluY-mediated deletion of exon 5 in the CPOX gene by MLPA analysis in patients with hereditary coproporphyriaM Barbaro, M Kotajärvi, P Harper, et al.European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|December 1, 1994
Acute intermittent porphyria: diagnostic conundrumsW S Wassif, A C Deacon, Y Floderus, et al.Cellular and Molecular Biology (Noisy-Le-Grand, France)|March 10, 2009
Porphyrin precursors and porphyrins in three patients with acute intermittent porphyria and end-stage renal disease under different therapy regimesE Sardh, D E H Andersson, A Henrichson, et al.Pageof 32